Jill Norris
Concepts (780)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autoimmunity | 74 | 2023 | 813 | 9.650 |
Why?
| Diabetes Mellitus, Type 1 | 114 | 2023 | 3244 | 8.410 |
Why?
| Islets of Langerhans | 56 | 2023 | 726 | 7.740 |
Why?
| Autoantibodies | 90 | 2023 | 1345 | 7.040 |
Why?
| Arthritis, Rheumatoid | 47 | 2024 | 1002 | 6.900 |
Why?
| Diet | 27 | 2024 | 1080 | 4.290 |
Why?
| Vitamin D | 21 | 2022 | 341 | 4.160 |
Why?
| Rheumatoid Factor | 22 | 2024 | 157 | 3.810 |
Why?
| Fatty Acids, Omega-3 | 13 | 2020 | 122 | 3.750 |
Why?
| Celiac Disease | 20 | 2022 | 264 | 3.250 |
Why?
| Anti-Citrullinated Protein Antibodies | 11 | 2023 | 90 | 3.210 |
Why?
| Genetic Predisposition to Disease | 67 | 2023 | 2084 | 3.110 |
Why?
| Risk Factors | 103 | 2023 | 8628 | 2.580 |
Why?
| Polymorphism, Single Nucleotide | 59 | 2023 | 1879 | 2.520 |
Why?
| Glutens | 9 | 2021 | 56 | 2.320 |
Why?
| Lupus Erythematosus, Systemic | 8 | 2022 | 219 | 2.310 |
Why?
| Peptides, Cyclic | 21 | 2023 | 253 | 2.250 |
Why?
| Erythrocyte Membrane | 6 | 2015 | 50 | 2.200 |
Why?
| Child, Preschool | 97 | 2023 | 9108 | 2.180 |
Why?
| Infant | 98 | 2023 | 7959 | 2.120 |
Why?
| Genome-Wide Association Study | 26 | 2023 | 1177 | 2.080 |
Why?
| Breast Feeding | 21 | 2021 | 368 | 2.040 |
Why?
| Female | 243 | 2023 | 59466 | 2.030 |
Why?
| Insulin Resistance | 43 | 2023 | 1072 | 2.010 |
Why?
| Prospective Studies | 65 | 2023 | 6217 | 2.000 |
Why?
| Male | 229 | 2023 | 55554 | 1.980 |
Why?
| Humans | 322 | 2024 | 114623 | 1.820 |
Why?
| Child | 111 | 2023 | 18404 | 1.790 |
Why?
| DNA Methylation | 4 | 2021 | 495 | 1.740 |
Why?
| Diabetes Mellitus, Type 2 | 34 | 2023 | 2094 | 1.740 |
Why?
| Family | 22 | 2023 | 589 | 1.730 |
Why?
| Adiposity | 19 | 2017 | 457 | 1.700 |
Why?
| Disease Progression | 29 | 2022 | 2380 | 1.660 |
Why?
| Oxylipins | 3 | 2023 | 27 | 1.650 |
Why?
| Vitamin D Deficiency | 6 | 2018 | 158 | 1.570 |
Why?
| Infant Nutritional Physiological Phenomena | 8 | 2021 | 133 | 1.490 |
Why?
| Milk | 11 | 2018 | 124 | 1.480 |
Why?
| Genotype | 50 | 2023 | 1760 | 1.410 |
Why?
| Infant Food | 9 | 2018 | 63 | 1.400 |
Why?
| Cohort Studies | 53 | 2022 | 4894 | 1.290 |
Why?
| Follow-Up Studies | 41 | 2021 | 4411 | 1.280 |
Why?
| Insulin | 27 | 2021 | 2076 | 1.250 |
Why?
| Adiponectin | 11 | 2018 | 213 | 1.240 |
Why?
| Middle Aged | 106 | 2021 | 26719 | 1.220 |
Why?
| Atherosclerosis | 18 | 2023 | 341 | 1.210 |
Why?
| Fatty Acids, Unsaturated | 3 | 2021 | 84 | 1.210 |
Why?
| Proportional Hazards Models | 19 | 2021 | 1075 | 1.200 |
Why?
| Body Mass Index | 32 | 2023 | 1956 | 1.160 |
Why?
| Eating | 6 | 2023 | 344 | 1.160 |
Why?
| Case-Control Studies | 33 | 2023 | 3003 | 1.150 |
Why?
| HLA-DR Antigens | 15 | 2017 | 219 | 1.150 |
Why?
| HLA-DR4 Antigen | 11 | 2021 | 76 | 1.130 |
Why?
| Prenatal Exposure Delayed Effects | 8 | 2023 | 452 | 1.110 |
Why?
| Adult | 115 | 2021 | 30528 | 1.090 |
Why?
| Dietary Proteins | 6 | 2019 | 122 | 1.090 |
Why?
| Dietary Sucrose | 2 | 2020 | 45 | 1.050 |
Why?
| Biomarkers | 25 | 2024 | 3408 | 1.040 |
Why?
| Infant, Newborn | 48 | 2022 | 5043 | 0.990 |
Why?
| Seroconversion | 2 | 2021 | 45 | 0.900 |
Why?
| Obesity | 21 | 2021 | 2507 | 0.900 |
Why?
| Metabolic Syndrome | 6 | 2021 | 321 | 0.870 |
Why?
| Colorado | 36 | 2020 | 4099 | 0.860 |
Why?
| Docosahexaenoic Acids | 5 | 2021 | 69 | 0.850 |
Why?
| Longitudinal Studies | 19 | 2020 | 2387 | 0.840 |
Why?
| Edible Grain | 5 | 2013 | 43 | 0.840 |
Why?
| Incidence | 21 | 2023 | 2311 | 0.830 |
Why?
| Infant Formula | 5 | 2019 | 74 | 0.800 |
Why?
| Autoimmune Diseases | 8 | 2019 | 382 | 0.790 |
Why?
| Child Nutritional Physiological Phenomena | 4 | 2019 | 97 | 0.780 |
Why?
| HLA-DR3 Antigen | 9 | 2023 | 79 | 0.770 |
Why?
| Blood Glucose | 16 | 2018 | 1819 | 0.760 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 43 | 0.760 |
Why?
| Epitopes | 5 | 2022 | 435 | 0.750 |
Why?
| Environmental Exposure | 4 | 2020 | 372 | 0.750 |
Why?
| Surveys and Questionnaires | 21 | 2022 | 4620 | 0.740 |
Why?
| Mass Screening | 8 | 2021 | 1004 | 0.740 |
Why?
| Adolescent | 57 | 2023 | 17831 | 0.740 |
Why?
| Metabolomics | 5 | 2023 | 521 | 0.740 |
Why?
| Transglutaminases | 11 | 2021 | 142 | 0.730 |
Why?
| F2-Isoprostanes | 2 | 2015 | 14 | 0.730 |
Why?
| Overweight | 6 | 2021 | 471 | 0.720 |
Why?
| HLA-DQ Antigens | 14 | 2018 | 174 | 0.700 |
Why?
| Fatty Acids, Omega-6 | 5 | 2020 | 45 | 0.700 |
Why?
| Pregnancy | 26 | 2023 | 5517 | 0.700 |
Why?
| Mexican Americans | 5 | 2019 | 101 | 0.690 |
Why?
| Sugars | 1 | 2020 | 29 | 0.690 |
Why?
| Inflammation Mediators | 4 | 2020 | 477 | 0.690 |
Why?
| Receptors, Calcitriol | 4 | 2016 | 53 | 0.680 |
Why?
| Age Factors | 25 | 2019 | 2894 | 0.680 |
Why?
| Phospholipids | 1 | 2021 | 197 | 0.670 |
Why?
| Phenotype | 27 | 2021 | 2796 | 0.650 |
Why?
| Genetic Variation | 8 | 2017 | 870 | 0.650 |
Why?
| Immunoglobulin G | 8 | 2023 | 770 | 0.640 |
Why?
| Genome, Human | 8 | 2017 | 347 | 0.630 |
Why?
| Gene Frequency | 16 | 2021 | 477 | 0.620 |
Why?
| Immunoglobulin A | 9 | 2023 | 166 | 0.620 |
Why?
| Aged | 47 | 2021 | 19061 | 0.610 |
Why?
| Polymorphism, Genetic | 11 | 2021 | 610 | 0.610 |
Why?
| Milk Proteins | 3 | 2008 | 36 | 0.610 |
Why?
| Hypertension, Pregnancy-Induced | 1 | 2018 | 45 | 0.610 |
Why?
| Maternal Nutritional Physiological Phenomena | 6 | 2021 | 141 | 0.600 |
Why?
| Family Health | 11 | 2017 | 193 | 0.590 |
Why?
| HLA Antigens | 14 | 2019 | 224 | 0.580 |
Why?
| Alleles | 13 | 2021 | 789 | 0.580 |
Why?
| Glutamate Decarboxylase | 12 | 2021 | 160 | 0.570 |
Why?
| Genetic Linkage | 11 | 2016 | 294 | 0.570 |
Why?
| Genetic Loci | 8 | 2020 | 262 | 0.560 |
Why?
| Cytokines | 7 | 2020 | 1840 | 0.550 |
Why?
| Air Pollution | 2 | 2024 | 169 | 0.550 |
Why?
| PPAR gamma | 3 | 2016 | 182 | 0.540 |
Why?
| Dietary Supplements | 7 | 2019 | 460 | 0.540 |
Why?
| Vitamin D3 24-Hydroxylase | 1 | 2016 | 14 | 0.540 |
Why?
| Arachidonic Acid | 2 | 2021 | 116 | 0.530 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 8 | 2019 | 46 | 0.530 |
Why?
| Dietary Carbohydrates | 2 | 2015 | 138 | 0.530 |
Why?
| Homeostasis | 15 | 2023 | 573 | 0.520 |
Why?
| Sputum | 4 | 2021 | 285 | 0.520 |
Why?
| Carbohydrates | 2 | 2015 | 55 | 0.520 |
Why?
| Diet Surveys | 7 | 2021 | 78 | 0.520 |
Why?
| Non-alcoholic Fatty Liver Disease | 6 | 2023 | 245 | 0.520 |
Why?
| Diabetes, Gestational | 7 | 2020 | 281 | 0.510 |
Why?
| Population Surveillance | 4 | 2015 | 392 | 0.500 |
Why?
| Feeding Methods | 1 | 2015 | 6 | 0.500 |
Why?
| Feeding Behavior | 4 | 2018 | 574 | 0.500 |
Why?
| Child Day Care Centers | 1 | 2015 | 33 | 0.490 |
Why?
| Altitude | 1 | 2018 | 432 | 0.480 |
Why?
| Glucose | 11 | 2023 | 896 | 0.460 |
Why?
| Joints | 3 | 2013 | 84 | 0.460 |
Why?
| Micronutrients | 3 | 2017 | 78 | 0.460 |
Why?
| Blood Pressure | 8 | 2020 | 1538 | 0.460 |
Why?
| Chemokines | 2 | 2012 | 216 | 0.460 |
Why?
| Pedigree | 11 | 2020 | 460 | 0.460 |
Why?
| Intra-Abdominal Fat | 10 | 2021 | 77 | 0.460 |
Why?
| Dietary Fats, Unsaturated | 3 | 2011 | 21 | 0.450 |
Why?
| Tobacco Smoke Pollution | 3 | 2007 | 217 | 0.450 |
Why?
| Energy Intake | 7 | 2023 | 427 | 0.450 |
Why?
| Stress, Psychological | 2 | 2020 | 944 | 0.440 |
Why?
| Diet Records | 5 | 2019 | 76 | 0.440 |
Why?
| Dietary Fats | 3 | 2011 | 287 | 0.440 |
Why?
| Fatty Acid Desaturases | 1 | 2013 | 29 | 0.440 |
Why?
| GTP-Binding Proteins | 5 | 2021 | 139 | 0.430 |
Why?
| Pediatrics | 2 | 2020 | 979 | 0.430 |
Why?
| Genetic Association Studies | 7 | 2020 | 339 | 0.430 |
Why?
| Smoking | 9 | 2019 | 1380 | 0.420 |
Why?
| Bacteroidaceae Infections | 1 | 2012 | 4 | 0.420 |
Why?
| United States | 38 | 2022 | 12176 | 0.420 |
Why?
| Porphyromonas gingivalis | 1 | 2012 | 17 | 0.420 |
Why?
| Cross-Sectional Studies | 12 | 2022 | 4405 | 0.420 |
Why?
| Multivariate Analysis | 12 | 2021 | 1430 | 0.420 |
Why?
| Pregnancy in Diabetics | 3 | 2012 | 82 | 0.420 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2012 | 11 | 0.410 |
Why?
| C-Reactive Protein | 6 | 2018 | 362 | 0.410 |
Why?
| Periodontitis | 1 | 2012 | 42 | 0.400 |
Why?
| Risk Assessment | 12 | 2020 | 2967 | 0.400 |
Why?
| Ascorbic Acid | 3 | 2023 | 110 | 0.400 |
Why?
| Fluorocarbons | 2 | 2023 | 94 | 0.400 |
Why?
| Antibodies, Bacterial | 1 | 2012 | 119 | 0.390 |
Why?
| Exome | 4 | 2021 | 200 | 0.390 |
Why?
| Age of Onset | 9 | 2018 | 445 | 0.390 |
Why?
| Calcifediol | 1 | 2011 | 29 | 0.380 |
Why?
| Texas | 8 | 2014 | 188 | 0.370 |
Why?
| Genetic Testing | 7 | 2020 | 379 | 0.370 |
Why?
| Logistic Models | 10 | 2019 | 1840 | 0.370 |
Why?
| RGS Proteins | 1 | 2011 | 12 | 0.370 |
Why?
| Fetal Blood | 5 | 2021 | 270 | 0.370 |
Why?
| Waist-Hip Ratio | 3 | 2007 | 30 | 0.370 |
Why?
| Extracellular Traps | 3 | 2021 | 40 | 0.370 |
Why?
| Europe | 12 | 2020 | 334 | 0.370 |
Why?
| Quantitative Trait, Heritable | 2 | 2017 | 116 | 0.360 |
Why?
| Food, Fortified | 1 | 2010 | 36 | 0.360 |
Why?
| Quantitative Trait Loci | 8 | 2020 | 305 | 0.350 |
Why?
| Diabetes Mellitus | 6 | 2020 | 900 | 0.350 |
Why?
| Epigenesis, Genetic | 3 | 2021 | 520 | 0.350 |
Why?
| Membrane Proteins | 6 | 2019 | 1018 | 0.350 |
Why?
| Exercise | 4 | 2021 | 1644 | 0.340 |
Why?
| Air Pollutants | 2 | 2024 | 242 | 0.340 |
Why?
| Food Preferences | 1 | 2011 | 108 | 0.340 |
Why?
| Enzyme-Linked Immunosorbent Assay | 7 | 2019 | 797 | 0.340 |
Why?
| Triglycerides | 5 | 2021 | 467 | 0.330 |
Why?
| Body Height | 2 | 2009 | 180 | 0.330 |
Why?
| Adipose Tissue | 7 | 2017 | 539 | 0.320 |
Why?
| Cholesterol, HDL | 4 | 2019 | 183 | 0.320 |
Why?
| HLA-DQ beta-Chains | 7 | 2015 | 57 | 0.320 |
Why?
| Life Style | 5 | 2015 | 430 | 0.310 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2021 | 740 | 0.310 |
Why?
| Glycemic Index | 1 | 2008 | 21 | 0.310 |
Why?
| Inflammation | 5 | 2022 | 2477 | 0.310 |
Why?
| Prenatal Nutritional Physiological Phenomena | 3 | 2017 | 57 | 0.310 |
Why?
| Vaccines | 2 | 2023 | 375 | 0.300 |
Why?
| Prognosis | 9 | 2021 | 3328 | 0.300 |
Why?
| Vitamins | 3 | 2024 | 151 | 0.300 |
Why?
| Calcitriol | 1 | 2008 | 53 | 0.300 |
Why?
| Odds Ratio | 7 | 2019 | 953 | 0.290 |
Why?
| Environmental Pollutants | 2 | 2024 | 110 | 0.290 |
Why?
| Lipid Metabolism | 3 | 2019 | 444 | 0.290 |
Why?
| Probiotics | 2 | 2019 | 46 | 0.280 |
Why?
| Lipase | 3 | 2019 | 55 | 0.280 |
Why?
| Young Adult | 21 | 2021 | 10455 | 0.280 |
Why?
| Bias | 3 | 2021 | 179 | 0.280 |
Why?
| Psychology, Child | 1 | 2007 | 37 | 0.280 |
Why?
| Precision Medicine | 2 | 2020 | 336 | 0.280 |
Why?
| Fetal Distress | 1 | 2006 | 12 | 0.270 |
Why?
| Linkage Disequilibrium | 5 | 2011 | 245 | 0.270 |
Why?
| Wheat Hypersensitivity | 1 | 2006 | 4 | 0.270 |
Why?
| Heat-Shock Proteins | 1 | 2007 | 113 | 0.270 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2006 | 23 | 0.270 |
Why?
| Abdominal Fat | 6 | 2017 | 39 | 0.270 |
Why?
| Immunoglobulin M | 5 | 2022 | 246 | 0.260 |
Why?
| Insulin Antibodies | 6 | 2016 | 102 | 0.260 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2006 | 64 | 0.260 |
Why?
| Vitamin D-Binding Protein | 3 | 2021 | 13 | 0.260 |
Why?
| C-Peptide | 4 | 2017 | 138 | 0.260 |
Why?
| Nutritional Status | 2 | 2013 | 287 | 0.260 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2021 | 1139 | 0.250 |
Why?
| Genetic Markers | 6 | 2013 | 320 | 0.250 |
Why?
| Protective Factors | 2 | 2016 | 87 | 0.250 |
Why?
| Autoantigens | 5 | 2021 | 396 | 0.250 |
Why?
| Sex Factors | 9 | 2019 | 1715 | 0.250 |
Why?
| Risk | 8 | 2019 | 812 | 0.250 |
Why?
| Insulin-Secreting Cells | 3 | 2018 | 317 | 0.250 |
Why?
| Hypertension | 5 | 2020 | 1056 | 0.250 |
Why?
| Animals | 19 | 2022 | 31694 | 0.240 |
Why?
| Time Factors | 15 | 2017 | 6112 | 0.240 |
Why?
| Cattle | 6 | 2017 | 920 | 0.240 |
Why?
| Infant, Newborn, Diseases | 1 | 2006 | 104 | 0.240 |
Why?
| Rubella | 2 | 2023 | 21 | 0.240 |
Why?
| Fatty Acids | 2 | 2021 | 381 | 0.240 |
Why?
| CpG Islands | 2 | 2021 | 117 | 0.240 |
Why?
| Chromosomes, Human, Pair 17 | 5 | 2008 | 56 | 0.230 |
Why?
| Body Composition | 5 | 2017 | 590 | 0.230 |
Why?
| Glucose Tolerance Test | 10 | 2018 | 343 | 0.230 |
Why?
| Fasting | 7 | 2015 | 240 | 0.230 |
Why?
| Alanine Transaminase | 3 | 2021 | 141 | 0.230 |
Why?
| Disease Susceptibility | 4 | 2020 | 316 | 0.230 |
Why?
| Erythrocytes | 2 | 2021 | 591 | 0.220 |
Why?
| Intestinal Mucosa | 1 | 2008 | 532 | 0.220 |
Why?
| Bottle Feeding | 2 | 2018 | 20 | 0.220 |
Why?
| Lipids | 4 | 2019 | 580 | 0.220 |
Why?
| Birth Weight | 3 | 2018 | 440 | 0.220 |
Why?
| Data Accuracy | 1 | 2024 | 48 | 0.220 |
Why?
| Mumps | 1 | 2023 | 23 | 0.220 |
Why?
| Interleukin-6 | 2 | 2021 | 676 | 0.220 |
Why?
| Seizures | 1 | 2006 | 340 | 0.220 |
Why?
| Arteriosclerosis | 6 | 2005 | 83 | 0.220 |
Why?
| Iron Overload | 1 | 2023 | 9 | 0.220 |
Why?
| Measles | 1 | 2023 | 38 | 0.220 |
Why?
| Chromosome Mapping | 11 | 2009 | 487 | 0.210 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2016 | 16 | 0.210 |
Why?
| Pediatric Obesity | 3 | 2018 | 488 | 0.210 |
Why?
| Chickenpox | 1 | 2023 | 93 | 0.210 |
Why?
| Protein-Arginine Deiminases | 3 | 2021 | 16 | 0.210 |
Why?
| Seroepidemiologic Studies | 3 | 2012 | 138 | 0.200 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 2 | 2021 | 58 | 0.200 |
Why?
| Nuclear Family | 3 | 2019 | 49 | 0.200 |
Why?
| Urine | 1 | 2002 | 54 | 0.200 |
Why?
| Citrullination | 2 | 2020 | 12 | 0.200 |
Why?
| Propensity Score | 1 | 2023 | 224 | 0.190 |
Why?
| Cotinine | 1 | 2002 | 69 | 0.190 |
Why?
| Tandem Mass Spectrometry | 2 | 2021 | 411 | 0.190 |
Why?
| Citrulline | 2 | 2016 | 40 | 0.190 |
Why?
| Aspartate Aminotransferases | 2 | 2019 | 86 | 0.190 |
Why?
| Sulfates | 1 | 2021 | 43 | 0.190 |
Why?
| Antibodies, Viral | 3 | 2019 | 520 | 0.190 |
Why?
| Hydroxyeicosatetraenoic Acids | 1 | 2021 | 40 | 0.190 |
Why?
| Liver Glycogen | 1 | 2021 | 17 | 0.190 |
Why?
| Sunlight | 1 | 2001 | 57 | 0.190 |
Why?
| Transcription Factors | 2 | 2019 | 1528 | 0.190 |
Why?
| Apolipoproteins E | 1 | 2021 | 80 | 0.190 |
Why?
| Linoleic Acid | 1 | 2021 | 37 | 0.190 |
Why?
| Lactones | 1 | 2021 | 54 | 0.190 |
Why?
| Registries | 9 | 2019 | 1767 | 0.190 |
Why?
| Health Status | 2 | 2023 | 722 | 0.180 |
Why?
| Arthralgia | 1 | 2021 | 46 | 0.180 |
Why?
| Protein Phosphatase 1 | 1 | 2021 | 28 | 0.180 |
Why?
| Specimen Handling | 1 | 2002 | 155 | 0.180 |
Why?
| Lod Score | 7 | 2017 | 65 | 0.180 |
Why?
| Glycogen Storage Disease | 1 | 2021 | 20 | 0.180 |
Why?
| Fatty Liver | 3 | 2013 | 210 | 0.180 |
Why?
| Prediabetic State | 3 | 2012 | 219 | 0.180 |
Why?
| Iodide Peroxidase | 1 | 2020 | 27 | 0.180 |
Why?
| Models, Genetic | 5 | 2017 | 562 | 0.180 |
Why?
| Origin of Life | 1 | 2020 | 9 | 0.180 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2020 | 8 | 0.180 |
Why?
| Reproducibility of Results | 8 | 2018 | 2762 | 0.180 |
Why?
| Isotopes | 1 | 2020 | 27 | 0.180 |
Why?
| Mental Recall | 4 | 2017 | 171 | 0.170 |
Why?
| Interleukin-8 | 1 | 2021 | 237 | 0.170 |
Why?
| Parents | 2 | 2007 | 1186 | 0.170 |
Why?
| Iron | 2 | 2023 | 233 | 0.170 |
Why?
| Peroxidase | 1 | 2020 | 163 | 0.170 |
Why?
| Aged, 80 and over | 15 | 2019 | 6344 | 0.170 |
Why?
| Self Report | 2 | 2022 | 696 | 0.170 |
Why?
| Gastroenteritis | 2 | 2019 | 65 | 0.170 |
Why?
| Survival Analysis | 4 | 2017 | 1211 | 0.170 |
Why?
| Toll-Like Receptors | 1 | 2020 | 167 | 0.170 |
Why?
| Linear Models | 3 | 2019 | 768 | 0.170 |
Why?
| Metabolic Clearance Rate | 3 | 2014 | 102 | 0.170 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2021 | 470 | 0.160 |
Why?
| Endocrinology | 1 | 2020 | 70 | 0.160 |
Why?
| Histones | 2 | 2021 | 535 | 0.160 |
Why?
| Antigens, Viral | 2 | 2019 | 176 | 0.160 |
Why?
| Transcription Factor 7-Like 2 Protein | 2 | 2017 | 24 | 0.160 |
Why?
| HLA-D Antigens | 2 | 2017 | 34 | 0.160 |
Why?
| Subcutaneous Fat | 5 | 2010 | 70 | 0.160 |
Why?
| Interleukin-1beta | 1 | 2021 | 370 | 0.160 |
Why?
| Health | 2 | 2013 | 74 | 0.160 |
Why?
| Herpesvirus 4, Human | 1 | 2019 | 125 | 0.160 |
Why?
| Antibodies | 3 | 2011 | 371 | 0.160 |
Why?
| Plasminogen Activator Inhibitor 1 | 2 | 2012 | 83 | 0.150 |
Why?
| Arthritis, Experimental | 1 | 2020 | 130 | 0.150 |
Why?
| Gestational Age | 4 | 2020 | 759 | 0.150 |
Why?
| Sensitivity and Specificity | 5 | 2015 | 1691 | 0.150 |
Why?
| Interleukins | 1 | 2020 | 236 | 0.150 |
Why?
| Chromatography, Liquid | 1 | 2019 | 347 | 0.150 |
Why?
| Herpesviridae Infections | 1 | 2019 | 138 | 0.150 |
Why?
| Consensus | 1 | 2020 | 537 | 0.150 |
Why?
| Monocytes | 1 | 2020 | 502 | 0.150 |
Why?
| Hypersensitivity | 1 | 2021 | 252 | 0.150 |
Why?
| Mucous Membrane | 1 | 2018 | 108 | 0.150 |
Why?
| Enterovirus Infections | 3 | 2010 | 160 | 0.150 |
Why?
| Collagen | 1 | 2020 | 415 | 0.150 |
Why?
| Retrospective Studies | 13 | 2022 | 12542 | 0.150 |
Why?
| Niacin | 1 | 2017 | 18 | 0.140 |
Why?
| Maternal Age | 3 | 2004 | 117 | 0.140 |
Why?
| Bone Density | 1 | 2021 | 432 | 0.140 |
Why?
| Mothers | 4 | 2018 | 651 | 0.140 |
Why?
| Oxidative Stress | 1 | 2003 | 1076 | 0.140 |
Why?
| Socioeconomic Factors | 5 | 2017 | 1077 | 0.140 |
Why?
| Myocardial Infarction | 2 | 2021 | 927 | 0.140 |
Why?
| Calcium | 1 | 2023 | 1104 | 0.140 |
Why?
| Algorithms | 2 | 2023 | 1466 | 0.140 |
Why?
| Tomography, X-Ray Computed | 9 | 2017 | 2279 | 0.140 |
Why?
| Sweden | 4 | 2018 | 65 | 0.140 |
Why?
| Neoplasm Proteins | 1 | 2020 | 384 | 0.140 |
Why?
| Immunity, Innate | 1 | 2022 | 720 | 0.140 |
Why?
| Eicosapentaenoic Acid | 2 | 2013 | 28 | 0.140 |
Why?
| Germany | 4 | 2018 | 84 | 0.140 |
Why?
| Respiratory Tract Infections | 2 | 2019 | 319 | 0.140 |
Why?
| NFI Transcription Factors | 1 | 2016 | 5 | 0.140 |
Why?
| Regression Analysis | 7 | 2017 | 944 | 0.140 |
Why?
| Cardiovascular Diseases | 4 | 2021 | 1727 | 0.130 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 367 | 0.130 |
Why?
| Databases, Factual | 2 | 2018 | 1124 | 0.130 |
Why?
| Laminin | 1 | 2016 | 69 | 0.130 |
Why?
| Prenatal Care | 2 | 2017 | 253 | 0.130 |
Why?
| Plasma Cells | 1 | 2016 | 56 | 0.130 |
Why?
| Complement System Proteins | 1 | 2019 | 282 | 0.130 |
Why?
| Prevalence | 5 | 2017 | 2249 | 0.130 |
Why?
| Hydrolases | 2 | 2021 | 51 | 0.130 |
Why?
| Microsatellite Repeats | 2 | 2014 | 136 | 0.130 |
Why?
| Adipogenesis | 1 | 2016 | 42 | 0.130 |
Why?
| Niacinamide | 1 | 2016 | 63 | 0.130 |
Why?
| Umbilical Cord | 1 | 2016 | 80 | 0.130 |
Why?
| Diet, High-Fat | 1 | 2017 | 225 | 0.130 |
Why?
| Haplotypes | 6 | 2008 | 448 | 0.130 |
Why?
| Predictive Value of Tests | 9 | 2018 | 1796 | 0.130 |
Why?
| Isocitrate Dehydrogenase | 1 | 2015 | 38 | 0.130 |
Why?
| Arthritis | 1 | 2016 | 109 | 0.130 |
Why?
| Environment | 3 | 2019 | 332 | 0.130 |
Why?
| Interleukin-2 | 2 | 2016 | 413 | 0.120 |
Why?
| Dietary Fiber | 1 | 2015 | 40 | 0.120 |
Why?
| Metabolome | 1 | 2018 | 282 | 0.120 |
Why?
| Early Diagnosis | 4 | 2019 | 217 | 0.120 |
Why?
| Mental Health | 1 | 2020 | 562 | 0.120 |
Why?
| Mutation Rate | 1 | 2015 | 26 | 0.120 |
Why?
| Hydrocarbons, Chlorinated | 1 | 2014 | 20 | 0.120 |
Why?
| Minority Groups | 3 | 2011 | 227 | 0.120 |
Why?
| Self Disclosure | 2 | 2007 | 59 | 0.120 |
Why?
| Gene-Environment Interaction | 4 | 2018 | 183 | 0.120 |
Why?
| Vaccination | 1 | 2022 | 1204 | 0.120 |
Why?
| Pesticides | 1 | 2014 | 49 | 0.120 |
Why?
| Liver | 5 | 2023 | 1634 | 0.120 |
Why?
| Serum Albumin, Bovine | 1 | 1994 | 61 | 0.110 |
Why?
| Beverages | 1 | 2014 | 60 | 0.110 |
Why?
| Selenoprotein P | 1 | 2013 | 3 | 0.110 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 386 | 0.110 |
Why?
| Siblings | 3 | 2010 | 221 | 0.110 |
Why?
| Leukocytes, Mononuclear | 1 | 2016 | 493 | 0.110 |
Why?
| Severity of Illness Index | 3 | 2019 | 2537 | 0.110 |
Why?
| Finland | 3 | 2018 | 69 | 0.110 |
Why?
| Asthma | 2 | 2023 | 2029 | 0.110 |
Why?
| Immunoglobulins | 2 | 2015 | 142 | 0.110 |
Why?
| Geographic Information Systems | 1 | 2013 | 37 | 0.110 |
Why?
| Quality of Life | 2 | 2020 | 2353 | 0.100 |
Why?
| Practice Guidelines as Topic | 1 | 2020 | 1394 | 0.100 |
Why?
| Interleukin-9 | 1 | 2012 | 10 | 0.100 |
Why?
| Genes, MHC Class II | 1 | 2012 | 69 | 0.100 |
Why?
| Chromosomes, Human, Pair 3 | 3 | 2010 | 49 | 0.100 |
Why?
| Tuberculosis, Bovine | 1 | 2012 | 3 | 0.100 |
Why?
| Cell Membrane | 1 | 2016 | 680 | 0.100 |
Why?
| Alcohol Drinking | 1 | 2018 | 651 | 0.100 |
Why?
| Patient Compliance | 2 | 2015 | 524 | 0.100 |
Why?
| Epistasis, Genetic | 3 | 2020 | 67 | 0.100 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 140 | 0.100 |
Why?
| HLA-DRB1 Chains | 3 | 2012 | 98 | 0.100 |
Why?
| Child of Impaired Parents | 1 | 2012 | 40 | 0.100 |
Why?
| 25-Hydroxyvitamin D 2 | 1 | 2011 | 7 | 0.100 |
Why?
| Body Fat Distribution | 2 | 2013 | 46 | 0.100 |
Why?
| Bronchial Diseases | 1 | 2011 | 38 | 0.100 |
Why?
| Fatty Acids, Nonesterified | 1 | 2012 | 151 | 0.100 |
Why?
| Particulate Matter | 1 | 2013 | 185 | 0.090 |
Why?
| Vegetables | 2 | 2013 | 133 | 0.090 |
Why?
| Histocompatibility Testing | 3 | 2007 | 116 | 0.090 |
Why?
| Environmental Monitoring | 1 | 2013 | 254 | 0.090 |
Why?
| Mice | 3 | 2022 | 14860 | 0.090 |
Why?
| Triticum | 1 | 2010 | 9 | 0.090 |
Why?
| Liver Cirrhosis | 2 | 2023 | 227 | 0.090 |
Why?
| Chi-Square Distribution | 1 | 2012 | 493 | 0.090 |
Why?
| Plant Proteins | 1 | 2011 | 81 | 0.090 |
Why?
| Peptide Fragments | 1 | 1994 | 665 | 0.090 |
Why?
| Statistics, Nonparametric | 2 | 2010 | 385 | 0.090 |
Why?
| Health Fairs | 1 | 2009 | 9 | 0.090 |
Why?
| DNA Primers | 3 | 2007 | 510 | 0.090 |
Why?
| Synovitis | 1 | 2009 | 24 | 0.080 |
Why?
| Chromosomes, Human, Pair 1 | 3 | 2004 | 66 | 0.080 |
Why?
| Biopsy | 3 | 2015 | 1036 | 0.080 |
Why?
| Gliadin | 1 | 2009 | 12 | 0.080 |
Why?
| Cholera Toxin | 1 | 2009 | 27 | 0.080 |
Why?
| Decision Support Techniques | 1 | 2013 | 355 | 0.080 |
Why?
| Fetal Weight | 1 | 2009 | 52 | 0.080 |
Why?
| I-kappa B Proteins | 1 | 2009 | 79 | 0.080 |
Why?
| Haptoglobins | 1 | 2009 | 47 | 0.080 |
Why?
| Receptors, Somatostatin | 1 | 2009 | 24 | 0.080 |
Why?
| Milk, Human | 1 | 2010 | 127 | 0.080 |
Why?
| Interferon-gamma | 1 | 2012 | 719 | 0.080 |
Why?
| Antigens, CD | 2 | 2009 | 442 | 0.080 |
Why?
| Intestinal Absorption | 1 | 2009 | 93 | 0.080 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 17 | 0.080 |
Why?
| Rheumatology | 1 | 2010 | 88 | 0.080 |
Why?
| Hypoglycemic Agents | 2 | 2015 | 1008 | 0.080 |
Why?
| Nutrition Assessment | 3 | 2017 | 75 | 0.080 |
Why?
| Seasons | 4 | 2019 | 442 | 0.080 |
Why?
| Protein Precursors | 1 | 2009 | 119 | 0.080 |
Why?
| Immunization | 2 | 2022 | 397 | 0.080 |
Why?
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 9 | 0.080 |
Why?
| Artificial Intelligence | 1 | 2010 | 144 | 0.080 |
Why?
| Gastrointestinal Tract | 1 | 2010 | 169 | 0.080 |
Why?
| Antirheumatic Agents | 2 | 2015 | 255 | 0.080 |
Why?
| Permeability | 1 | 2008 | 149 | 0.080 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2023 | 22 | 0.080 |
Why?
| Solanum tuberosum | 1 | 2008 | 7 | 0.080 |
Why?
| Organ Specificity | 2 | 2019 | 268 | 0.080 |
Why?
| Influenza Vaccines | 1 | 2012 | 497 | 0.070 |
Why?
| TCF Transcription Factors | 1 | 2007 | 20 | 0.070 |
Why?
| Diabetic Ketoacidosis | 1 | 2009 | 159 | 0.070 |
Why?
| HLA-DP Antigens | 1 | 2007 | 32 | 0.070 |
Why?
| Seafood | 1 | 2007 | 16 | 0.070 |
Why?
| gamma-Glutamyltransferase | 2 | 2019 | 42 | 0.070 |
Why?
| Genotyping Techniques | 2 | 2017 | 69 | 0.070 |
Why?
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2007 | 42 | 0.070 |
Why?
| Influenza, Human | 1 | 2012 | 546 | 0.070 |
Why?
| Carotenoids | 1 | 2007 | 35 | 0.070 |
Why?
| Mutation | 1 | 2017 | 3344 | 0.070 |
Why?
| Fluorescent Antibody Technique | 2 | 2020 | 397 | 0.070 |
Why?
| Rotavirus | 1 | 2006 | 22 | 0.070 |
Why?
| Societies, Medical | 2 | 2020 | 663 | 0.070 |
Why?
| Plethysmography | 2 | 2017 | 103 | 0.070 |
Why?
| Cholesterol, LDL | 2 | 2019 | 307 | 0.070 |
Why?
| Delivery, Obstetric | 2 | 2004 | 118 | 0.070 |
Why?
| Weight Gain | 1 | 2009 | 453 | 0.070 |
Why?
| Rotavirus Infections | 1 | 2006 | 50 | 0.070 |
Why?
| Glucose Intolerance | 2 | 2008 | 136 | 0.070 |
Why?
| Amino Acid Substitution | 1 | 2007 | 262 | 0.070 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2006 | 58 | 0.070 |
Why?
| Health Behavior | 1 | 2012 | 704 | 0.070 |
Why?
| Polymerase Chain Reaction | 4 | 2016 | 993 | 0.060 |
Why?
| DNA | 2 | 2009 | 1352 | 0.060 |
Why?
| Pro-Opiomelanocortin | 1 | 2005 | 17 | 0.060 |
Why?
| Fibrinogen | 2 | 2019 | 154 | 0.060 |
Why?
| Gene Expression Regulation | 3 | 2016 | 2319 | 0.060 |
Why?
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2005 | 4 | 0.060 |
Why?
| Lung Diseases | 1 | 2011 | 701 | 0.060 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 2005 | 39 | 0.060 |
Why?
| Genome Components | 1 | 2005 | 2 | 0.060 |
Why?
| Postpartum Period | 2 | 2021 | 278 | 0.060 |
Why?
| Aging | 2 | 2009 | 1618 | 0.060 |
Why?
| Codon | 1 | 2005 | 86 | 0.060 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 811 | 0.060 |
Why?
| Sleep | 1 | 2010 | 631 | 0.060 |
Why?
| Amino Acid Sequence | 3 | 1999 | 1982 | 0.060 |
Why?
| Arthritis, Juvenile | 1 | 2005 | 42 | 0.060 |
Why?
| Gastrointestinal Diseases | 2 | 2019 | 182 | 0.060 |
Why?
| Albuminuria | 1 | 2005 | 164 | 0.060 |
Why?
| Intestine, Small | 1 | 2005 | 122 | 0.060 |
Why?
| Likelihood Functions | 3 | 2012 | 126 | 0.060 |
Why?
| Pulmonary Fibrosis | 1 | 2007 | 323 | 0.060 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2004 | 44 | 0.060 |
Why?
| Phospholipases | 1 | 2023 | 12 | 0.060 |
Why?
| Sequence Analysis, DNA | 2 | 2017 | 723 | 0.060 |
Why?
| Embryonic and Fetal Development | 1 | 2003 | 94 | 0.060 |
Why?
| Radiography | 3 | 2013 | 812 | 0.060 |
Why?
| Acyltransferases | 1 | 2023 | 46 | 0.050 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 351 | 0.050 |
Why?
| Iron, Dietary | 1 | 2023 | 19 | 0.050 |
Why?
| Transforming Growth Factor beta | 2 | 2022 | 448 | 0.050 |
Why?
| Abdomen | 1 | 2003 | 99 | 0.050 |
Why?
| Proteins | 1 | 2009 | 908 | 0.050 |
Why?
| Protein Tyrosine Phosphatases | 3 | 2004 | 147 | 0.050 |
Why?
| Urban Health | 2 | 2006 | 73 | 0.050 |
Why?
| Glutamates | 1 | 2023 | 57 | 0.050 |
Why?
| Income | 1 | 2003 | 167 | 0.050 |
Why?
| Nerve Tissue Proteins | 2 | 2019 | 529 | 0.050 |
Why?
| Nutrition Surveys | 2 | 2014 | 224 | 0.050 |
Why?
| Nitrates | 1 | 1992 | 72 | 0.050 |
Why?
| Immunoglobulin Isotypes | 1 | 2022 | 32 | 0.050 |
Why?
| Water Supply | 1 | 1992 | 70 | 0.050 |
Why?
| Epidemiologic Studies | 1 | 2021 | 57 | 0.050 |
Why?
| Pseudomonas Infections | 1 | 2003 | 184 | 0.050 |
Why?
| Selection Bias | 1 | 2021 | 33 | 0.050 |
Why?
| Immunization Schedule | 1 | 2022 | 184 | 0.050 |
Why?
| Diagnostic Techniques, Radioisotope | 1 | 2021 | 8 | 0.050 |
Why?
| Prostatic Neoplasms | 1 | 2008 | 921 | 0.050 |
Why?
| Immunoglobulin D | 1 | 2021 | 27 | 0.050 |
Why?
| Serologic Tests | 1 | 2021 | 49 | 0.050 |
Why?
| Pregnancy Trimester, Third | 1 | 2021 | 78 | 0.050 |
Why?
| Waist Circumference | 2 | 2013 | 122 | 0.050 |
Why?
| Electrochemical Techniques | 1 | 2021 | 45 | 0.040 |
Why?
| Probability | 1 | 2021 | 289 | 0.040 |
Why?
| Financial Management | 1 | 2020 | 15 | 0.040 |
Why?
| Asymptomatic Diseases | 1 | 2021 | 75 | 0.040 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 94 | 0.040 |
Why?
| Residence Characteristics | 2 | 2019 | 275 | 0.040 |
Why?
| Synovial Fluid | 1 | 2020 | 56 | 0.040 |
Why?
| Interleukin-10 | 1 | 2022 | 299 | 0.040 |
Why?
| Databases, Genetic | 1 | 2021 | 206 | 0.040 |
Why?
| Energy Metabolism | 2 | 2018 | 731 | 0.040 |
Why?
| Glucose Transporter Type 2 | 1 | 2019 | 10 | 0.040 |
Why?
| Mannose | 1 | 2019 | 21 | 0.040 |
Why?
| Pregnancy Complications, Infectious | 1 | 2003 | 288 | 0.040 |
Why?
| Laryngitis | 1 | 2019 | 3 | 0.040 |
Why?
| Immunophenotyping | 1 | 2020 | 274 | 0.040 |
Why?
| Body Weight | 2 | 2017 | 868 | 0.040 |
Why?
| Norway | 1 | 2019 | 36 | 0.040 |
Why?
| Health Equity | 1 | 2020 | 53 | 0.040 |
Why?
| Adenosine Diphosphate | 1 | 2019 | 81 | 0.040 |
Why?
| Sequence Homology | 1 | 1999 | 39 | 0.040 |
Why?
| Conjunctivitis | 1 | 2019 | 17 | 0.040 |
Why?
| Immunoglobulin E | 1 | 2021 | 314 | 0.040 |
Why?
| Health Plan Implementation | 1 | 2020 | 132 | 0.040 |
Why?
| Butyrates | 1 | 2019 | 53 | 0.040 |
Why?
| Maternal Behavior | 1 | 1999 | 70 | 0.040 |
Why?
| LIM-Homeodomain Proteins | 1 | 2019 | 14 | 0.040 |
Why?
| Methotrexate | 1 | 2020 | 226 | 0.040 |
Why?
| Brazil | 1 | 2019 | 89 | 0.040 |
Why?
| Outpatients | 1 | 1992 | 326 | 0.040 |
Why?
| Hospitalization | 2 | 2004 | 1749 | 0.040 |
Why?
| Powders | 1 | 2018 | 38 | 0.040 |
Why?
| Health Services | 1 | 1999 | 103 | 0.040 |
Why?
| Tobacco Products | 1 | 2019 | 98 | 0.040 |
Why?
| Fever | 1 | 2019 | 280 | 0.040 |
Why?
| Small-Area Analysis | 1 | 1997 | 8 | 0.040 |
Why?
| Forecasting | 1 | 2019 | 330 | 0.040 |
Why?
| Multiple Trauma | 1 | 1998 | 96 | 0.040 |
Why?
| Microtubule-Associated Proteins | 1 | 2019 | 174 | 0.040 |
Why?
| Diastole | 1 | 2018 | 130 | 0.040 |
Why?
| Community Health Planning | 1 | 1997 | 43 | 0.040 |
Why?
| Systole | 1 | 2018 | 171 | 0.040 |
Why?
| Whooping Cough | 1 | 1997 | 49 | 0.040 |
Why?
| Multiple Organ Failure | 1 | 1998 | 146 | 0.040 |
Why?
| Discriminant Analysis | 1 | 2017 | 37 | 0.040 |
Why?
| Calcium-Binding Proteins | 1 | 2019 | 206 | 0.040 |
Why?
| Pilot Projects | 1 | 2002 | 1372 | 0.040 |
Why?
| Health Planning | 1 | 1997 | 46 | 0.040 |
Why?
| Otitis Media | 1 | 2019 | 142 | 0.040 |
Why?
| Muscle Proteins | 1 | 2019 | 210 | 0.040 |
Why?
| Cholesterol | 1 | 2019 | 367 | 0.040 |
Why?
| Insurance, Health | 1 | 1999 | 244 | 0.040 |
Why?
| Blood Group Antigens | 1 | 1997 | 14 | 0.030 |
Why?
| CTLA-4 Antigen | 2 | 2009 | 76 | 0.030 |
Why?
| Molecular Weight | 1 | 2017 | 331 | 0.030 |
Why?
| DNA Mutational Analysis | 2 | 2010 | 372 | 0.030 |
Why?
| Genes, Immunoglobulin Light Chain | 1 | 2016 | 6 | 0.030 |
Why?
| Genes, Immunoglobulin Heavy Chain | 1 | 2016 | 10 | 0.030 |
Why?
| Phosphofructokinase-2 | 1 | 2016 | 14 | 0.030 |
Why?
| Acute Disease | 1 | 2019 | 910 | 0.030 |
Why?
| Diabetes Complications | 1 | 2018 | 211 | 0.030 |
Why?
| Data Collection | 1 | 2019 | 620 | 0.030 |
Why?
| Models, Biological | 2 | 2019 | 1620 | 0.030 |
Why?
| Antibody Formation | 1 | 2018 | 266 | 0.030 |
Why?
| Endpoint Determination | 1 | 2017 | 68 | 0.030 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 63 | 0.030 |
Why?
| Complement Activation | 1 | 2019 | 340 | 0.030 |
Why?
| Th17 Cells | 1 | 2016 | 58 | 0.030 |
Why?
| Sirtuin 1 | 1 | 2016 | 29 | 0.030 |
Why?
| Los Angeles | 2 | 2008 | 56 | 0.030 |
Why?
| Enterovirus | 1 | 1997 | 72 | 0.030 |
Why?
| Mortality | 2 | 2007 | 287 | 0.030 |
Why?
| Evidence-Based Medicine | 1 | 2020 | 668 | 0.030 |
Why?
| Alzheimer Disease | 1 | 2021 | 442 | 0.030 |
Why?
| Infant Mortality | 1 | 1996 | 91 | 0.030 |
Why?
| Protein Isoforms | 1 | 2017 | 338 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2017 | 620 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 1997 | 182 | 0.030 |
Why?
| Patient-Centered Care | 1 | 2020 | 473 | 0.030 |
Why?
| Georgia | 1 | 2015 | 62 | 0.030 |
Why?
| Florida | 1 | 2015 | 73 | 0.030 |
Why?
| Symptom Assessment | 1 | 2016 | 119 | 0.030 |
Why?
| Synovial Membrane | 1 | 2015 | 75 | 0.030 |
Why?
| Australia | 1 | 1996 | 206 | 0.030 |
Why?
| Glucose-6-Phosphatase | 1 | 2015 | 31 | 0.030 |
Why?
| Erythrocyte Count | 1 | 2014 | 19 | 0.030 |
Why?
| North America | 1 | 1996 | 256 | 0.030 |
Why?
| Washington | 1 | 2015 | 134 | 0.030 |
Why?
| Databases, Nucleic Acid | 1 | 2014 | 31 | 0.030 |
Why?
| Blood Proteins | 1 | 1997 | 231 | 0.030 |
Why?
| Solubility | 1 | 2015 | 223 | 0.030 |
Why?
| Rituximab | 1 | 2015 | 150 | 0.030 |
Why?
| Hematocrit | 1 | 2014 | 87 | 0.030 |
Why?
| Cross-Cultural Comparison | 1 | 2015 | 77 | 0.030 |
Why?
| Biomedical Research | 1 | 2020 | 585 | 0.030 |
Why?
| Isoenzymes | 2 | 2006 | 283 | 0.030 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 71 | 0.030 |
Why?
| Datasets as Topic | 1 | 2014 | 99 | 0.030 |
Why?
| Cholesterol Ester Transfer Proteins | 1 | 2014 | 17 | 0.030 |
Why?
| Apolipoproteins | 1 | 2014 | 36 | 0.030 |
Why?
| Treatment Outcome | 2 | 2004 | 9084 | 0.030 |
Why?
| Leukocyte Count | 1 | 2014 | 293 | 0.030 |
Why?
| Family Characteristics | 1 | 2015 | 151 | 0.030 |
Why?
| Antibodies, Antinuclear | 1 | 2014 | 58 | 0.030 |
Why?
| Lipoproteins, HDL | 1 | 2014 | 75 | 0.030 |
Why?
| Birth Order | 2 | 2004 | 12 | 0.030 |
Why?
| Cystic Fibrosis | 1 | 2003 | 955 | 0.030 |
Why?
| Neurocan | 1 | 2013 | 1 | 0.030 |
Why?
| Histocompatibility Antigens Class II | 2 | 2008 | 352 | 0.030 |
Why?
| Chondroitin Sulfate Proteoglycans | 1 | 2013 | 9 | 0.030 |
Why?
| Plant Roots | 1 | 2013 | 34 | 0.030 |
Why?
| Lysophospholipase | 1 | 2013 | 10 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 439 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2014 | 181 | 0.030 |
Why?
| Lectins, C-Type | 1 | 2013 | 61 | 0.030 |
Why?
| Amino Acids, Branched-Chain | 1 | 2013 | 31 | 0.030 |
Why?
| Fetal Development | 1 | 2016 | 246 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 1997 | 2785 | 0.030 |
Why?
| Phosphoprotein Phosphatases | 1 | 2013 | 64 | 0.030 |
Why?
| Public Health | 1 | 2017 | 433 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 687 | 0.030 |
Why?
| Promoter Regions, Genetic | 2 | 2009 | 1131 | 0.030 |
Why?
| Lung | 2 | 2017 | 3558 | 0.030 |
Why?
| HLA-DR2 Antigen | 1 | 2012 | 8 | 0.030 |
Why?
| Culture | 1 | 2013 | 124 | 0.030 |
Why?
| Fruit | 1 | 2013 | 127 | 0.030 |
Why?
| Hemoglobins | 1 | 2014 | 315 | 0.030 |
Why?
| Antigens | 1 | 1994 | 318 | 0.030 |
Why?
| Vaccines, Inactivated | 1 | 2012 | 68 | 0.030 |
Why?
| Intestines | 1 | 2015 | 326 | 0.030 |
Why?
| Ireland | 1 | 2012 | 24 | 0.030 |
Why?
| Models, Statistical | 2 | 2009 | 599 | 0.030 |
Why?
| Genome | 1 | 2014 | 271 | 0.030 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2012 | 75 | 0.030 |
Why?
| Feasibility Studies | 1 | 2015 | 739 | 0.030 |
Why?
| Tuberculin Test | 1 | 2012 | 32 | 0.030 |
Why?
| Sentinel Surveillance | 1 | 2012 | 38 | 0.020 |
Why?
| Arthrography | 1 | 2011 | 22 | 0.020 |
Why?
| Academic Medical Centers | 1 | 1994 | 410 | 0.020 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1177 | 0.020 |
Why?
| Solvents | 1 | 2012 | 104 | 0.020 |
Why?
| ROC Curve | 1 | 2013 | 442 | 0.020 |
Why?
| Anxiety Disorders | 1 | 1994 | 303 | 0.020 |
Why?
| Silicon Dioxide | 1 | 2012 | 88 | 0.020 |
Why?
| Child Abuse | 1 | 1996 | 456 | 0.020 |
Why?
| Indians, North American | 1 | 1997 | 570 | 0.020 |
Why?
| Leptin | 1 | 2012 | 210 | 0.020 |
Why?
| Dyslipidemias | 1 | 2013 | 154 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2015 | 1842 | 0.020 |
Why?
| Blood Glucose Self-Monitoring | 1 | 2015 | 498 | 0.020 |
Why?
| Congresses as Topic | 1 | 2012 | 195 | 0.020 |
Why?
| Women's Health | 1 | 2013 | 271 | 0.020 |
Why?
| Diabetic Angiopathies | 1 | 2012 | 244 | 0.020 |
Why?
| Obesity, Abdominal | 1 | 2010 | 37 | 0.020 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2009 | 52 | 0.020 |
Why?
| Sample Size | 1 | 2010 | 112 | 0.020 |
Why?
| Ultraviolet Rays | 1 | 2012 | 363 | 0.020 |
Why?
| Space-Time Clustering | 1 | 1989 | 3 | 0.020 |
Why?
| Actuarial Analysis | 1 | 1989 | 21 | 0.020 |
Why?
| Maternal Exposure | 1 | 2011 | 138 | 0.020 |
Why?
| Community-Institutional Relations | 1 | 2009 | 89 | 0.020 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2009 | 27 | 0.020 |
Why?
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2008 | 7 | 0.020 |
Why?
| Disease | 1 | 2010 | 85 | 0.020 |
Why?
| Wounds and Injuries | 1 | 1996 | 745 | 0.020 |
Why?
| Southwestern United States | 1 | 2009 | 91 | 0.020 |
Why?
| Body Weights and Measures | 1 | 2008 | 34 | 0.020 |
Why?
| Genetic Carrier Screening | 1 | 2008 | 24 | 0.020 |
Why?
| Health Surveys | 1 | 2010 | 443 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2017 | 4689 | 0.020 |
Why?
| Coxsackievirus Infections | 1 | 1987 | 12 | 0.020 |
Why?
| Sleep Deprivation | 1 | 2010 | 166 | 0.020 |
Why?
| Sex Distribution | 1 | 2008 | 337 | 0.020 |
Why?
| Reference Values | 2 | 1999 | 742 | 0.020 |
Why?
| Survival | 1 | 2007 | 37 | 0.020 |
Why?
| Cause of Death | 1 | 1989 | 361 | 0.020 |
Why?
| RNA, Viral | 1 | 2010 | 565 | 0.020 |
Why?
| Spleen | 1 | 2009 | 487 | 0.020 |
Why?
| Recurrence | 1 | 2010 | 935 | 0.020 |
Why?
| HLA-DP beta-Chains | 1 | 2007 | 76 | 0.020 |
Why?
| Urban Population | 1 | 2009 | 397 | 0.020 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2006 | 44 | 0.020 |
Why?
| Base Sequence | 1 | 2010 | 2114 | 0.020 |
Why?
| Rural Health | 1 | 2006 | 67 | 0.020 |
Why?
| Rural Population | 1 | 2009 | 446 | 0.020 |
Why?
| Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.020 |
Why?
| Subcutaneous Fat, Abdominal | 1 | 2005 | 13 | 0.020 |
Why?
| Antigens, Differentiation | 1 | 2005 | 79 | 0.020 |
Why?
| Gene Expression | 1 | 2010 | 1421 | 0.020 |
Why?
| Albumins | 1 | 2005 | 89 | 0.010 |
Why?
| Interleukin-13 | 1 | 2005 | 122 | 0.010 |
Why?
| Primary Health Care | 1 | 1994 | 1512 | 0.010 |
Why?
| Open Reading Frames | 1 | 2005 | 116 | 0.010 |
Why?
| Interleukin-4 | 1 | 2005 | 206 | 0.010 |
Why?
| 3' Untranslated Regions | 1 | 2005 | 129 | 0.010 |
Why?
| Motor Activity | 1 | 2009 | 640 | 0.010 |
Why?
| Pancreatitis | 1 | 2005 | 107 | 0.010 |
Why?
| False Positive Reactions | 1 | 2004 | 109 | 0.010 |
Why?
| Models, Theoretical | 1 | 2008 | 515 | 0.010 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2003 | 16 | 0.010 |
Why?
| Growth | 1 | 2004 | 55 | 0.010 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2003 | 24 | 0.010 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 2003 | 22 | 0.010 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2003 | 30 | 0.010 |
Why?
| Adult Children | 1 | 2003 | 21 | 0.010 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2003 | 33 | 0.010 |
Why?
| Radioimmunoassay | 1 | 2004 | 162 | 0.010 |
Why?
| Single-Blind Method | 1 | 2004 | 258 | 0.010 |
Why?
| Confidence Intervals | 1 | 2004 | 305 | 0.010 |
Why?
| Creatinine | 1 | 2005 | 425 | 0.010 |
Why?
| Genetics, Population | 1 | 2004 | 188 | 0.010 |
Why?
| Remission Induction | 1 | 2004 | 233 | 0.010 |
Why?
| Transforming Growth Factor beta1 | 1 | 2004 | 153 | 0.010 |
Why?
| Causality | 1 | 2003 | 103 | 0.010 |
Why?
| Monte Carlo Method | 1 | 2003 | 138 | 0.010 |
Why?
| Survival Rate | 1 | 2006 | 1644 | 0.010 |
Why?
| HLA-A Antigens | 1 | 2002 | 49 | 0.010 |
Why?
| Epidemiologic Methods | 1 | 1992 | 72 | 0.010 |
Why?
| Neonatal Screening | 1 | 2003 | 152 | 0.010 |
Why?
| Morbidity | 1 | 1992 | 280 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2010 | 3531 | 0.010 |
Why?
| Pseudomonas aeruginosa | 1 | 2003 | 298 | 0.010 |
Why?
| Histocompatibility Antigens Class I | 1 | 2002 | 172 | 0.010 |
Why?
| Double-Blind Method | 1 | 2004 | 1660 | 0.010 |
Why?
| Haemophilus influenzae type b | 1 | 1999 | 10 | 0.010 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 25 | 0.010 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 1999 | 22 | 0.010 |
Why?
| Haemophilus Vaccines | 1 | 1999 | 27 | 0.010 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2004 | 1214 | 0.010 |
Why?
| Capitation Fee | 1 | 1999 | 13 | 0.010 |
Why?
| Hepatitis B Vaccines | 1 | 1999 | 46 | 0.010 |
Why?
| Chronic Disease | 1 | 2005 | 1578 | 0.010 |
Why?
| Genetic Counseling | 1 | 1999 | 65 | 0.010 |
Why?
| Office Visits | 1 | 1999 | 79 | 0.010 |
Why?
| Fee-for-Service Plans | 1 | 1999 | 83 | 0.010 |
Why?
| Medical Records | 1 | 1999 | 153 | 0.010 |
Why?
| Platelet Count | 1 | 1998 | 81 | 0.010 |
Why?
| APACHE | 1 | 1998 | 58 | 0.010 |
Why?
| Lymphocyte Count | 1 | 1998 | 133 | 0.010 |
Why?
| Coronary Artery Disease | 1 | 2004 | 607 | 0.010 |
Why?
| CD4 Lymphocyte Count | 1 | 1998 | 257 | 0.010 |
Why?
| Fluid Therapy | 1 | 1998 | 123 | 0.010 |
Why?
| Population Density | 1 | 1997 | 94 | 0.010 |
Why?
| Demography | 1 | 1998 | 260 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 65 | 0.010 |
Why?
| Age Distribution | 1 | 1997 | 342 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 309 | 0.010 |
Why?
| Marital Status | 1 | 1996 | 41 | 0.010 |
Why?
| Bacterial Infections | 1 | 1998 | 218 | 0.010 |
Why?
| Injury Severity Score | 1 | 1998 | 499 | 0.010 |
Why?
| Quality Control | 1 | 1996 | 144 | 0.010 |
Why?
| Virus Diseases | 1 | 1998 | 194 | 0.010 |
Why?
| Marriage | 1 | 1997 | 106 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 383 | 0.010 |
Why?
| Blood Transfusion | 1 | 1998 | 293 | 0.010 |
Why?
| Neoplasms | 1 | 1989 | 2097 | 0.010 |
Why?
| Medicaid | 1 | 1999 | 406 | 0.010 |
Why?
| Viral Proteins | 1 | 1997 | 281 | 0.010 |
Why?
| Poverty | 1 | 1997 | 442 | 0.010 |
Why?
| Sex Characteristics | 1 | 1998 | 640 | 0.010 |
Why?
| Skinfold Thickness | 1 | 1992 | 49 | 0.010 |
Why?
| Psychiatric Status Rating Scales | 1 | 1994 | 482 | 0.010 |
Why?
| Emergency Medical Services | 1 | 1999 | 590 | 0.010 |
Why?
| Patient Discharge | 1 | 1997 | 771 | 0.010 |
Why?
| Psychometrics | 1 | 1994 | 608 | 0.010 |
Why?
|
|
Norris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|